[HTML][HTML] More treatment but no less depression: The treatment-prevalence paradox

J Ormel, SD Hollon, RC Kessler, P Cuijpers… - Clinical psychology …, 2022 - Elsevier
Treatments for depression have improved, and their availability has markedly increased
since the 1980s. Mysteriously the general population prevalence of depression has not …

Treatment selection in depression

ZD Cohen, RJ DeRubeis - Annual review of clinical psychology, 2018 - annualreviews.org
Mental health researchers and clinicians have long sought answers to the question “What
works for whom?” The goal of precision medicine is to provide evidence-based answers to …

A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression

P Cuijpers, H Noma, E Karyotaki, CH Vinkers… - World …, 2020 - Wiley Online Library
No network meta‐analysis has examined the relative effects of psychotherapies,
pharmacotherapies and their combination in the treatment of adult depression, while this is a …

Positive affect treatment targets reward sensitivity: A randomized controlled trial.

MG Craske, AE Meuret, A Echiverri-Cohen… - Journal of Consulting …, 2023 - psycnet.apa.org
Objective: Determine whether a novel psychosocial treatment for positive affect improves
clinical status and reward sensitivity more than a form of cognitive behavioral therapy that …

Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia.

MG Craske, AE Meuret, T Ritz, M Treanor… - Journal of consulting …, 2019 - psycnet.apa.org
Objective: Loss of pleasure or interest in activities (ie, anhedonia) is a risk factor for
suicidality, treatment nonresponse, and relapse. Extant treatments that focus on reducing …

How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta‐analytic update of the evidence

P Cuijpers, IA Cristea, E Karyotaki… - World …, 2016 - Wiley Online Library
We report the current best estimate of the effects of cognitive behavior therapy (CBT) in the
treatment of major depression (MDD), generalized anxiety disorder (GAD), panic disorder …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …

JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC psychiatry, 2017 - Springer
Background The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …

Prevalencia, causas y tratamiento de la depresión Mayor

EA Pérez-Padilla, VM Cervantes-Ramírez… - Revista …, 2017 - scielo.org.mx
La depresión mayor representa un problema de salud pública debido a su alta prevalencia.
La etiología de la depresión es compleja ya que en ella intervienen factores psicosociales …

Current definitions of “transdiagnostic” in treatment development: A search for consensus

S Sauer-Zavala, CA Gutner, TJ Farchione… - Behavior therapy, 2017 - Elsevier
Research in psychopathology has identified psychological processes that are relevant
across a range of Diagnostic and Statistical Manual (DSM) mental disorders, and these …